ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC18163-50mg |
|
912287-56-0 |
YHO-13177
|
0 | C20H22N2O3S | |
GC18163-100mg |
|
912287-56-0 |
YHO-13177
|
0 | C20H22N2O3S | |
GC18163-10mg |
|
912287-56-0 |
YHO-13177
|
0 | C20H22N2O3S | |
GC18163-5mg |
|
912287-56-0 |
YHO-13177
|
0 | C20H22N2O3S | |
GC18162-1g |
|
842959-64-2 |
(QUINAZOLIN-4-YLOXY)-ACETIC ACID
|
0 | C10H8N2O3 | |
GC18162-500mg |
|
842959-64-2 |
(QUINAZOLIN-4-YLOXY)-ACETIC ACID
|
0 | C10H8N2O3 | |
GC18161-100mg |
|
432529-82-3 |
BCI-121
|
0 | C14H18BrN3O2 | |
GC18161-25mg |
|
432529-82-3 |
BCI-121
|
0 | C14H18BrN3O2 | |
GC18161-5mg |
|
432529-82-3 |
BCI-121
|
0 | C14H18BrN3O2 | |
GC18160-1g |
|
1247825-37-1 |
USP7/USP47 inhibitor
|
0 | C18H11Cl2N3O3S3 | |
GC18160-500mg |
|
1247825-37-1 |
USP7/USP47 inhibitor
|
0 | C18H11Cl2N3O3S3 | |
GC18160-50mg |
|
1247825-37-1 |
USP7/USP47 inhibitor
|
0 | C18H11Cl2N3O3S3 | |
GC18160-10mg |
|
1247825-37-1 |
USP7/USP47 inhibitor
|
0 | C18H11Cl2N3O3S3 | |
GC18160-5mg |
|
1247825-37-1 |
USP7/USP47 inhibitor
|
0 | C18H11Cl2N3O3S3 | |
GC18159-25mg |
|
1906919-67-2 |
BAY-598
|
0 | C22H20Cl2F2N6O3 | |
GC18159-10mg |
|
1906919-67-2 |
BAY-598
|
0 | C22H20Cl2F2N6O3 | |
GC18159-5mg |
|
1906919-67-2 |
BAY-598
|
0 | C22H20Cl2F2N6O3 | |
GC18158-25g |
|
14663-53-7 |
2-(4-Oxoquinazolin-3(4H)-yl)acetic acid
|
0 | C10H8N2O3 | |
GC18158-5g |
|
14663-53-7 |
2-(4-Oxoquinazolin-3(4H)-yl)acetic acid
|
0 | C10H8N2O3 | |
GC18157-25g |
|
490-91-5 |
Thymoquinone
|
0 | C10H12O2 | |